Skip to content
News Home img

Financial news

Date Title and Summary Additional Formats
Toggle Summary Walgreens Boots Alliance to Host Sell-Side Analyst Event

General financial news

DEERFIELD, Ill. --(BUSINESS WIRE)--May 7, 2018-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA ) announced today it will hold a Sell-Side Analyst Event on Tuesday, 22 May in New York City . The event will be hosted by Walgreens Boots Alliance Executive Vice Chairman and CEO Stefano Pessina , Co-Chief
View HTML
Toggle Summary Walgreens Boots Alliance Declares Regular Quarterly Dividend

Dividend

DEERFIELD, Ill. --(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period. The dividend is payable 12 June 2018 to stockholders of
View HTML
Toggle Summary Walgreens Boots Alliance Reports Fiscal 2018 Second Quarter Results

Earnings

Second quarter highlights GAAP diluted net earnings per share were $1.36 , up 38.8 percent from the year-ago quarter; Adjusted diluted net earnings per share increase 27.2 percent to $1.73 GAAP net earnings attributable to Walgreens Boots Alliance increase 27.3 percent, to $1.3 billion ; Adjusted
View HTML
Toggle Summary Walgreens Boots Alliance Appoints James Kehoe Global Chief Financial Officer

General financial news

Kehoe previously served as chief financial officer and board director of Takeda Pharmaceutical Company Limited. Kehoe takes over from George Fairweather , who played a key role in the Walgreens -Alliance Boots merger and subsequent integration and development, and has decided to step down after a
View HTML
Toggle Summary Walgreens Boots Alliance Schedules Fiscal 2018 Second Quarter Earnings Announcement for 28 March 2018

General financial news

DEERFIELD, Ill. --(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2018 second quarter earnings results at 7 a.m. Eastern time Wednesday , 28 March 2018 , followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m.
View HTML
Toggle Summary Walgreens Boots Alliance Appoints Sebastian James as Senior Vice President and President and Managing Director of Boots

General financial news

DEERFIELD, Ill. --(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Sebastian James as Senior Vice President and President and Managing Director of Boots. He also will be contributing to the Group with involvement in a number of key areas, joining the
View HTML
Toggle Summary Walgreens Boots Alliance Declares Regular Quarterly Dividend

Dividend

DEERFIELD, Ill. --(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period. The dividend is payable 12 March 2018 to stockholders of
View HTML
Toggle Summary Walgreens Boots Alliance to Webcast Annual Meeting of Stockholders

General financial news

DEERFIELD, Ill. --(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will provide a live webcast of its annual meeting of stockholders beginning at 8:30 a.m. MST ( 10:30 a.m. EST ) on Wednesday, 17 January 2018 . The meeting will be held at Andaz Scottsdale Resort & Spa , 6114 North
View HTML
Toggle Summary Walgreens Boots Alliance Publishes 2017 Corporate Social Responsibility Report

General financial news

DEERFIELD, Ill. --(BUSINESS WIRE)-- Walgreens Boots Alliance (Nasdaq:WBA) today published its 2017 Corporate Social Responsibility (CSR) Report covering the company's progress during the fiscal year ended 31 August 2017 . The report shows how the company is setting the pace on sustainability issues
View HTML
Toggle Summary Walgreens Boots Alliance Reports Fiscal 2018 First Quarter Results

Earnings

First quarter highlights GAAP diluted net earnings per share were $0.81 , down 16.5 percent from the year-ago quarter mainly due to impairment of the company's equity method investment in Guangzhou Pharmaceuticals Corporation ; Adjusted diluted net earnings per share were $1.28 , an increase of
View HTML

You must be logged in to view this item.

Please enter the following new information, or login and update your current entry. As a registered user, you will be able to use your new ID and password immediately to access special features. When registering as an accredited media user, you will be able to access high resolution photography and media contact lists within one business day.